Genetic variation at the scavenger receptor class B type I gene locus determines plasma lipoprotein concentrations and particle size and interacts with type 2 diabetes: The Framingham study

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 6, 2003, Pages 2869-2879

  Osgood, Doreen ^a   Corella, Dolores ^a   Demissie, Serkalem ^b   Cupples, L Adrienne ^b   Wilson, Peter W F ^c,d   Meigs, James B ^e   Schaefer, Ernst J ^a   Coltell, Oscar ^a   Ordovas, Jose M ^a  

^a TUFTS UNIVERSITY   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d FRAMINGHAM HEART STUDY   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SCAVENGER RECEPTOR; SCAVENGER RECEPTOR BI; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ANTHROPOMETRY; ARTICLE; CHEMICAL ANALYSIS; CHOLESTEROL BLOOD LEVEL; CONCENTRATION (PARAMETERS); DISEASE ASSOCIATION; EVALUATION; EXON; FEMALE; GENE LOCUS; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; INTRON; LIFESTYLE; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PARTICLE SIZE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

STAPHYLOCOCCUS PHAGE 187;

EID: 0038578149     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-021664     Document Type: Article

References (57)

1. Howard BV, Cowan LD, Go O, Welty TK, Robbins DC, Lee ET 1998 Adverse effects of diabetes on multiple cardiovascular disease risk factors in women. The Strong Heart Study. Diabetes Care 21:1258-1265
2. Taskinen MR 2002 Diabetic dyslipidemia. Atherosclerosis Suppl 3:47-51
3. Franceschini G 2001 Epidemiologic evidence for high-density lipoprotein cholesterol as a risk factor for coronary artery disease. Am J Cardiol 88:9-13
4. Erkelens DW 2001 Insulin resistance syndrome and type 2 diabetes mellitus. Am J Cardiol 88:38-42
5. Ford ES, Giles WH, Dietz WH 2002 Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287:356-359
6. Stein O, Stein Y 1999 Atheroprotective mechanisms of HDL. Atherosclerosis 144:285-301
7. Silver DL, Jiang XC, Arai T, Bruce C, Tall AR 2000 Receptors and lipid transfer proteins in HDL metabolism. Ann N Y Acad Sci 902:103-111
8. Acton S, Rigotti A, Landschulz KT, Xu S, Hobbs HH, Krieger M 1996 Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 271:518-520
9. Kozarsky KF, Donahee MH, Rigotti A, Iqbal SN, Edelman ER, Krieger M 1997 Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels. Nature 387:414-417
10. Wang N, Arai T, Ji Y, Rinninger F, Tall AR 1998 Liver-specific overexpression of scavenger receptor BI decreases levels of very low density lipoprotein ApoB, low density lipoprotein ApoB, and high density lipoprotein in transgenic mice. Biol Chem 273:32920-32926
11. Rigotti A, Trigatti BL, Penman M, Rayburn H, Herz J, Krieger M 1997 A targeted mutation in the routine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. Proc Natl Acad Sci USA 94:12610-12615
12. Varban ML, Rinninger F, Wang N, Fairchild-Huntress V, Dunmore JH, Fang Q, Gosselin ML, Dixon KL, Deeds JD, Acton SL, Tall AR, Huszar D 1998 Targeted mutation reveals a central role for SR-BI in hepatic selective uptake of high density lipoprotein cholesterol. Proc Natl Acad Sci USA 95:4619-4624
13. Ueda Y, Gong E, Royer L, Cooper PN, Francone OL, Rubin EM 2000 Relationship between expression levels and atherogenesis in scavenger receptor class B, type I transgenics. J Biol Chem 275:20368-20373
14. Xu S, Laccotripe M, Huang X, Rigotti A, Zannis VI, Krieger M 1997 Apolipoproteins of HDL can directly mediate binding to the scavenger receptor SR-BI, an HDL receptor that mediates selective lipid uptake. J Lipid Res 38:1289-1298
15. Ueda Y, Royer L, Gong E, Zhang J, Cooper PN, Francone O, Rubin EM 1999 Lower plasma levels and accelerated clearance of high density lipoprotein (HDL) and non-HDL cholesterol in scavenger receptor class B type I transgenic mice. J Biol Chem 274:7165-7171
16. Huszar D, Varban ML, Rinninger F, Feeley R, Arai T, Fairchild-Huntress V, Donovan MJ, Tall AR 2000 Increased LDL cholesterol and atherosclerosis in LDL receptor-deficient mice with attenuated expression of scavenger receptor B1. Arterioscler Thromb Vasc Biol 20:1068-1073
17. Acton S, Osgood D, Donoghue M, Corella D, Pocovi M, Cenarro A, Mozas P, Keilty J, Squazzo S, Woolf EA, Ordovas JM 1999 Association of polymorphisms at the SR-BI gene locus with plasma lipid levels and body mass index in a white population. Arterioscler Thromb Vasc Biol 19:1734-1743
18. Cao G, Garcia CK, Wyne KL, Schultz RA, Parker KL, Hobbs HH 1997 Structure and localization of the human gene encoding SR-BI/CLA-1. Evidence for transcriptional control by steroidogenic factor 1. J Biol Chem 272:33068-33076
19. Vaxillaire M, Boccio V, Philippi A, Vigouroux C, Terwilliger J, Passa P, Beckmann JS, Velho G, Lathrop GM, Froguel P 1995 A gene for maturity onset diabetes of the young (MODY) maps to chromosome 12q. Nat Genet 9:418-423
20. Mahtani MM, Widen E, Lehto M, Thomas J, McCarthy M, Brayer J, Bryant B, Chan G, Daly M, Forsblom C, Kanninen T, Kirby A, Kruglyak L, Munnelly K, Parkkonen M, Reeve-Daly MP, Weaver A, Brettin T, Duyk G, Lander ES, Groop LC 1996 Mapping of a gene for type 2 diabetes associated with an insulin secretion defect by a genome scan in Finnish families. Nat Genet 14:90-94
21. Bektas A, Suprenant ME, Wogan LT, Plengvidhya N, Rich SS, Warram JH, Krolewski AS, Doria A 1996 Evidence of a novel type 2 diabetes locus 50 cM centromeric to NIDDM2 on chromosome 12q. Diabetes 48:2246-2251
22. Lindgren CM, Mahtani MM, Widen E, McCarthy MI, Daly MJ, Kirby A, Reeve MP, Kruglyak L, Parker A, Meyer J, Almgren P, Lehto M, Kanninen T, Tuomi T, Groop LC, Lander ES 2002 Genomewide search for type 2 diabetes mellitus susceptibility loci in Finnish families: the Botnia study. Am J Hum Genet 70:509-516
23. Goff Jr DC, D'Agostino Jr RB, Haffner SM, Saad MF, Wagenknecht LE 2000 Lipoprotein concentrations and carotid atherosclerosis by diabetes status: results from the Insulin Resistance Atherosclerosis Study. Diabetes Care 23:1006-1011
24. Tan KC, Ai VH, Chow WS, Chau MT, Leong L, Lam KS 1999 Influence of low density lipoprotein (LDL) subfraction profile and LDL oxidation on endothelium-dependent and independent vasodilation in patients with type 2 diabetes. J Clin Endocrinol Metab 84:3212-3216
25. Feinleib M, Kannel WB, Garrison RJ, McNamara PM, Castelli WP 1975 The Framingham Offspring Study. Design and preliminary data. Prev Med 4:518-525
26. Kannel WB, Feinlieb M, McNamara PM, Garrison NJ, Castelli WP 1979 An investigation of coronary heart disease in families: the Framingham Offspring Study. Am J Epidemiol 110:281-290
27. Meigs JB, Larson MG, D'Agostino RB, Levy D, Clouse ME, Nathan DM, Wilson PW, O'Donnell CJ 2002 Coronary artery calcification in type 2 diabetes and insulin resistance: the Framingham Offspring Study. Diabetes Care 25:1313-1319
28. Cupples LA, Gagnon DR, Kannel WB 1992 Long- and short-term risk of sudden coronary death. Circulation 85:111-118
29. Friedewald WT, Levy RI, Fredrickson DS 1972 Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem 18:499-502
30. Gidez LI, Miller GJ, Burstein M, Slagle S, Eder HA 1982 Separation and quantitation of subclasses of human plasma HDL by simple precipitation procedure. J Lipid Res 23:1206-1233
31. Ordovas JM, Peterson JP, Santaniello P, Cohn J, Wilson PWF, Schaefer EJ 1987 Enzyme linked immunosorbent assay for human apolipoprotein B. J Lipid Res 28:1216-1224
32. Ordovas JM, Cupples LA, Corella D, Otvos JD, Osgood D, Martinez A, Lahoz C, Coltell O, Wilson PW, Schaefer EJ 2000 Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study. Arterioscler Thromb Vasc Biol 20:1323-1329
33. Otvos JD, Jeyarajah EJ, Bennett DW, Krauss RM 1992 Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement. Clin Chem 38:1632-1638
34. Meigs JB, Ordovas JM, Cupples LA, Singer DE, Nathan DM, Schaefer EJ, Wilson PW 2000 Apolipoprotein E isoform polymorphisms are not associated with insulin resistance: the Framingham Offspring Study. Diabetes Care 23:669-674
35. Osgood-McWeeney D, Galluzzi JR, Ordovas JM 2000 Allelic discrimination for single nucleotide polymorphisms in the human scavenger receptor class B type 1 gene locus using fluorescent probes. Clin Chem 46:118-119
36. Hixson JE, Vernier DT 1990 Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31:545-548
37. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA 2002 Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70:425-434
38. Lewontin RC 1964 The interaction of selection and linkage. I. General considerations: heterotic models. Genetics 49:49-67
39. Krieger M 1999 Charting the fate of the "good cholesterol": identification and characterization of the high-density lipoprotein receptor SR-BI. Annu Rev Biochem 68:523-558
40. Trigatti BL, Rigotti A, Braun A 2000 Cellular and physiological roles of SR-BI, a lipoprotein receptor which mediates selective lipid uptake. Biochim Biophys Acta 1529:276-286
41. Durst R, Colombo R, Shpitzen S, Avi LB, Friedlander Y, Wexler R, Raal FJ, Marais DA, Defesche JC, Mandelshtam MY, Kotze MJ, Leitersdorf E, Meiner V 2001 Recent origin and spread of a common Lithuanian mutation, G197del LDLR, causing familial hypercholesterolemia: positive selection is not always necessary to account for disease incidence among Ashkenazi Jews. Am J Hum Genet 68:1172-1188
42. Plat J, Mensink RP 2002 Relationship of genetic variation in genes encoding apolipoprotein A-IV, scavenger receptor BI, HMG-CoA reductase, CETP and apolipoprotein E with cholesterol metabolism and the response to plant stanol ester consumption. Eur J Clin Invest 32:242-250
43. Milliat F, Gripois D, Blouquit M-E, Ferezou J, Serougne C, Fidge NH, Lutton C 2000 Short and long-term effects of streptozotocin on dietary cholesterol absorption, plasma lipoproteins and liver lipoprotein receptors in RICO rats. Exp Clin Endocrinol Diabetes 108:436-446
44. Krieger M 2001 Scavenger receptor class B type I is a multiligand HDL receptor that influences diverse physiologic systems. J Clin Invest 108:793-797
45. de Beer FC, Connell PM, Yu J, de Beer MC, Webb NR, van der Westhuyzen DR 2000 HDL modification by secretory phospholipase A(2) promotes scavenger receptor class B type I interaction and accelerates HDL catabolism. J Lipid Res 41:1849-1857
46. de Beer MC, Durbin DM, Cai L, Jonas A, de Beer FC, van der Westhuyzen DR 2001 Apolipoprotein A-I conformation markedly influences HDL interaction with scavenger receptor BI. J Lipid Res 42:309-313
47. Gu X, Trigatti B, Xu S, Acton S, Babitt J, Krieger M 1998 The efficient cellular uptake of high density lipoprotein lipids via scavenger receptor class B type I requires not only receptor-mediated surface binding but also receptor-specific lipid transfer mediated by its extracellular domain. J Biol Chem 273:26338-26348
48. Braun A, Trigatti BL, Post MJ, Sato K, Simons M, Edelberg JM, Rosenberg RD, Schrenzel M, Krieger M 2002 Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice. Circ Res 90:270-276
49. Arai T, Wang N, Bezouevski M, Welch C, Tall AR 1999 Decreased atherosclerosis in heterozygous low density lipoprotein receptor-deficient mice expressing the scavenger receptor BI transgene. J Biol Chem 274:2366-2371
50. Kozarsky KF, Donahee MH, Glick JM, Krieger M, Rader DJ 2000 Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse. Arterioscler Thromb Vasc Biol 20:721-727
51. Greene DJ, Skeggs JW, Morton RE 2001 Elevated triglyceride content diminishes the capacity of high density lipoprotein to deliver cholesteryl esters via the scavenger receptor class B type I (SR-BI). J Biol Chem 276:4804-4811
52. Gillotte-Taylor K, Boullier A, Witztum JL, Steinberg D, Quehenberger O 2001 Scavenger receptor class B type I as a receptor for oxidized low density lipoprotein. J Lipid Res 42:1474-1482
53. Iwashima Y, Eto M, Hata A, Kaku K, Horiuchi S, Ushikubi F, Sano H 2000 Advanced glycation end products-induced gene expression of scavenger receptors in cultured human monocyte-derived macrophages. Biochem Biophys Res Commun 277:368-380
54. Nofer JR, Kehrel B, Fobker M, Levkau B, Assmann G, von Eckardstein A 2002 HDL and arteriosclerosis: beyond reverse cholesterol transport. Atherosclerosis 161:1-16
55. Calabresi L, Franceschini G 1997 High density lipoprotein and coronary heart disease: insights from mutations leading to low high density lipoprotein. Curr Opin Lipidol 8:219-224
56. Cohen JC, Vega GL, Grundy SM 1999 Hepatic lipase: new insights from genetic and metabolic studies. Curr Opin Lipidol 10:259-267
57. Hirano K, Yamashita S, Matsuzawa Y 2000 Pros and cons of inhibiting cholesteryl ester transfer protein. Curr Opin Lipidol 11:589-596